Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
Biological age & clocks
Video summary

Video description on geroscience: hallmarks, epigenetic clocks and the TAME metformin trial

The description says the listed sources cover the twelve hallmarks of ageing, epigenetic clocks such as GrimAge for predicting mortality, the TAME trial on metformin's anti-ageing potential, and partial cellular reprogramming; it frames ageing as potentially modifiable. [1]

Automatic summary · not editorially reviewed

The key findings

  1. The description says the sources highlight the twelve hallmarks of ageing, including cellular senescence and mitochondrial decay, and epigenetic clocks such as GrimAge to predict mortality. [1]

  2. The description states that the TAME trial investigates the anti-ageing potential of existing drugs like metformin and that biotech firms pursue partial cellular reprogramming. [1]

  3. The description says the collection illustrates a shift toward treating ageing as a modifiable biological process rather than an inevitable decline. [1]

The source at a glance

Study type / format
Video description
Population / context
Sources listed in the video description on longevity science
Summary based on
Creator description
Original publication
April 8, 2026

Hallmarks and GrimAge in the described sources

According to the description, the sources highlight the twelve hallmarks of ageing, including cellular senescence and mitochondrial decay. They also describe the development of epigenetic clocks such as GrimAge, which the description says are used to predict mortality. These are presented as research topics in the listed sources, not as results of a study conducted for this video.

Supporting source [1]

TAME trial and reprogramming as described topics

The description states that clinical initiatives such as the TAME trial investigate the anti-ageing potential of existing drugs like metformin. It also says cutting-edge biotech firms pursue partial cellular reprogramming to rejuvenate tissues. The description does not report trial results, participant numbers or outcomes; it only names these as areas the sources explore.

Supporting source [1]

Framing ageing as modifiable in the description

The description says the collection illustrates a shift toward treating ageing as a modifiable biological process rather than an inevitable decline. It also mentions that the texts address the role of medical professionals in distinguishing evidence-based interventions from commercially driven pseudoscience. This is the description's characterisation of the sources, not a demonstrated finding.

Supporting source [1]

How to interpret this

This is based only on the supplied video description; the video and transcript were not reviewed. The description names research topics without reporting study designs, samples, results or uncertainty, and its claims are attributed to the description and creator.

Based on the creator’s description; the full video and transcript were not analyzed.

Source & supporting passages

[1]
The Science of Living Longer

Gooseberry Science and Education Videos · youtube.com · April 8, 2026

Read the quoted passagesIn the language of the original source
  1. Finding 1 ↑

    twelve hallmarks of ageing, including cellular senescence
  2. Finding 2 ↑

    TAME trial investigate the anti-ageing potential
  3. Finding 3 ↑

    ageing as a modifiable biological process

AI-assisted summary with linked source passages. No independent editorial or clinical review.

Our editorial method

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…